Interruption of pregnancy by PGF2 alpha. I. Intraamniotic administration.
D000028:Abortion, Induced; D000022:Abortion, Spontaneous; D000293:Adolescent; D000328:Adult; D000649:Amniocentesis; D000650:Amnion; D000653:Amniotic Fluid; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006982:Hypertonic Solutions / Q000008:administration & dosage; D007263:Infusions, Parenteral; D007267:Injections; D010121:Oxytocin / Q000008:administration & dosage; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*; D012965:Sodium Chloride / Q000008:administration & dosage; D013997:Time Factors; D014599:Uterus / Q000187:drug effects*
D006982:Hypertonic Solutions; D011453:Prostaglandins; D012965:Sodium Chloride; D010121:Oxytocin